Evaluation of Outcomes With Umbilical Cord Allograft for Musculoskeletal Conditions Musculoskeletal Conditions

Starting soon · Not applicable

Conditions studied: Osteoarthritis, Tendinitis, Sports Injury, Degenerative Disc Disease, Degenerative Arthritis, Ligament Injury, Neuropathy, Pelvic Pain

In brief

The aim of the study is to determine the efficacy of an Amniotic Fluid Tissue Product for pain relief and functional improvements for all types of musculoskeletal conditions. The study is prospective, with outcome measures being obtained at numerous time points after the regenerative procedure.

Key facts

Study ID

NCT03390920

Run by

R3 Stem Cell

People needed

200

Starts

2022-01-01

Expected to finish

2030-01-01

Last updated by the study team

2021-09-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age 18 and over.
• Ability to attend follow up visits or at least converse on phone or complete email follow up forms.
• Competent to understand the study protocol and provide voluntary informed consent.

You may not qualify if…

• Active Infection
• Pregnancy, Lactating
• Clotting disorder

Where it is running

• Advanced Stem Cell Institute — Encino, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.